Health experts all over the world are rushing to find a cure for the Coronavirus Disease 2019 (COVID-19), which has already killed thousands of individuals worldwide. However, a vaccine or cure can take months or even years for it to be publicly available, which is why the World Health Organization (WHO) has launched the Solidarity Trial.
The Solidarity Trial aims to find a cure for the disease by testing drugs specifically used to combat SARS-COV2—the virus that causes COVID-19. Department of Health (DOH) Undersecretary Maria Rosario Vergeire said that the drugs that will be used in the trial have not been tested largely against the said coronavirus strain.
“The Solidarity Trial will compare four treatment options against the standard of care, to assess their relative effectiveness against COVID-19,” WHO said. “By enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival.”
WHO says that over 100 countries are now part of the trial and are working together to find a cure as soon as possible. One of these countries is the Philippines, which has 81 representatives in the Solidarity Trial.
These 81 Filipinos come from the following hospitals:
- Makati Medical Center (19 patients)
- Philippine General Hospital (14 patients)
- Lung Center of the Philippines (13 patients)
- The Medical City (10 patients)
- University of the East Ramon Magsaysay Medical Center (5 patients)
- Manila Medical Center (5 patients)
- Cardinal Santos Medical Center (4 patients)
- Asian Hospital and Medical Center (4 patients)
- San Lazaro Hospital (3 patients)
- St. Luke’s Medical Center – Quezon City (2 patients)
- St. Luke’s Medical Center – Global City (1 patient)
- Manila Doctors Hospital (1 patient)
The drugs that will be tested for the Solidarity Trial are antiviral Remdesivir, antimalarial drug Chloroquine or Hydroxychloroquine, antiretroviral drugs used to treat HIV Lopinavir with Ritonavir, and Interferon beta-1a drug used to treat multiple sclerosis.